- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02940171
Timing of Surgery And Outcome in Burn Patients ( EARLYBURN ) (EARLYBURN)
May 11, 2026 updated by: Assistance Publique - Hôpitaux de Paris
Impact of Timing of Surgery on Outcome of Severely Ill Burn Patients
The prognostic of burn patients has improved over the last decades.
Early excision of full thickness burns is thought to be one of the key factors which have led to prognostic improvement.
Best timing for burn excision remain uncertain, however.
In this multicenter observational study, we aim at exploring the impact of timing of surgery on outcome in severely ill burn patients using a propensity analysis.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The first aim of the study is to explore the impact of timing of the first surgery on outcome of severely ill burn patients.
Because a randomization would not be feasible in this setting, we will use a propensity analysis in matching patients receiving early surgery and those receiving late surgery.
Secondary aims are to evaluate the impact of the timing of surgery on morbidity (organs failure, infections, sepsis) but also to assess the diagnostic and prognostic value of plasma and urine biomarkers in severely ill burn patients
Study Type
Observational
Enrollment (Actual)
470
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France, 75010
- Departement of Anesthesiology, Critical Care and Burn Unit; Saint-Louis hospital, University Paris Diderot
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patients with extensive skin burns, defined as greater than 20% of the total body surface
Description
Inclusion Criteria:
- Age >18 years
- Admission to a burn unit within 72 hours from a burn injury
- Total burned surface area (TBSA)>20%(2nd degree or 3rd degree) for any type of burn
- Patient covered by the social security
- Non-opposition to participate to the study and to the constitution of the biological collection
Exclusion Criteria:
- Decline to participate
- Decision not to resuscitate order before surgery
- Pregnant or breastfeeding patiente
- Decision to limit therapies in the first 24 hours
- Patient not resident in France
- Patient deprived of liberty
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Early surgery
Early Excision of full thickness burn First excision surgery of full -thickness burn performed within 48 hours from burn injury
|
first excision surgery of full -thickness burn performed within 48 hours from burn injury
Other Names:
|
|
Late surgery
Late Excision of full thickness burn First excision surgery of full -thickness burn performed after 48 hours from burn injury
|
first excision surgery of full -thickness burn performed after 48 hours from burn injury
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
mortality
Time Frame: 90 days
|
90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Median Sequential Organ Failure Assessment score (SOFA score) during first 28 days
Time Frame: First 28 days
|
Median Sequential Organ Failure Assessment score (SOFA score) during first 28
|
First 28 days
|
|
One year mortality
Time Frame: One year
|
One year mortality
|
One year
|
|
Organ failure
Time Frame: 28 and 60 days
|
28 and 60 days
|
|
|
Recovery from acute kidney
Time Frame: Until 28 and 60 days from burn injury
|
Until 28 and 60 days from burn injury
|
|
|
Nosocomial infections (numbers) during first 60 days
Time Frame: First 60 days
|
Nosocomial infections (numbers) during first 60 days
|
First 60 days
|
|
Nosocomial sepsis during first 60 days
Time Frame: First 60 days
|
Nosocomial sepsis during first 60 days
|
First 60 days
|
|
Length of stay in the ICU
Time Frame: One year
|
Length of stay in the ICU
|
One year
|
|
analog scale of quality of life
Time Frame: One year
|
Functional sequel at one year, the patient will assesassess his overall quality of life since his accident Scale 1 to 10, with 1: poor, 10: good
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Matthieu Dr Legrand, MD, PhD, Saint-Louis Hospital, Paris, France
- Principal Investigator: Mourad BENYAMINA, MD, PH, Saint-Louis Hospital, Paris, France
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 25, 2016
Primary Completion (Actual)
December 11, 2023
Study Completion (Actual)
December 11, 2023
Study Registration Dates
First Submitted
October 17, 2016
First Submitted That Met QC Criteria
October 19, 2016
First Posted (Estimated)
October 20, 2016
Study Record Updates
Last Update Posted (Actual)
May 14, 2026
Last Update Submitted That Met QC Criteria
May 11, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NI 14029
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burns
-
Fondation Ophtalmologique Adolphe de RothschildNot yet recruiting
-
American Scitech InternationalJohnson & JohnsonUnknownBurns | Electric BurnsUnited States
-
MediWound LtdUnknownBurns, Upper Extremity | Burns, Lower ExtremitySlovakia
-
Singapore General HospitalUnknownAcute Thermal BurnsSingapore
-
RenovaCare, IncActive, not recruitingBurns | Burns Second Degree | Burns Deep Second DegreeUnited States
-
Sun Yat-sen UniversityCompleted
-
Hennepin Healthcare Research InstituteNot yet recruiting
-
Buckinghamshire Healthcare NHS TrustNot yet recruitingBurns Multiple
-
Virginia Commonwealth UniversityNot yet recruiting
-
Riphah International UniversityActive, not recruiting
Clinical Trials on Early Excision of full thickness burn
-
University of Roma La SapienzaUniversità Politecnica delle MarcheCompleted
-
State Scientific Centre of Coloproctology, Russian...RecruitingColorectal Neoplasms, BenignRussian Federation
-
Al-Azhar UniversityCompletedFull Thickness Mucoperiosteal Flap Versus Low Level Laser in Orthodontic Tooth Movement AccelerationMesial Movement of TeethEgypt
-
Algernon PharmaceuticalsCompletedIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Universitätsklinikum Hamburg-EppendorfOvesco Endoscopy AGSuspendedSubmucosal Tumor of StomachGermany
-
Peter NovakCompletedParkinson Disease | Multiple System AtrophyUnited States
-
University of PittsburghArmed Forces Institute of Regenerative MedicineNot yet recruitingBurns | Surgical Injury | Contracture ScarUnited States
-
WinSanTor, IncNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Eastern...CompletedDiabetes Mellitus | Painful Diabetic NeuropathyUnited States
-
Ahmed AoufCompletedConstipation | RECTUM | Hirschprung's DiseaseEgypt
-
University of AthensCompletedConcentration of Exhaled Carbon MonoxideGreece